July 2019

Steinberg Global Asset Management increased Loews Corp (L) stake by 367.86% reported in 2019Q1 SEC filing. Steinberg Global Asset Management acquired 18,393 shares as Loews Corp (L)’s stock rose 9.51%. The Steinberg Global Asset Management holds 23,393 shares with $1.12M value, up from 5,000 last quarter. Loews Corp now has $16.40B valuation. The stock decreased […]

A tiny molecule known as microRNA-142 plays a key role in the prevention of autoimmune responses through immune cells called regulatory T-cells (Tregs), according to a new study of  mice. These findings could enable new strategies to treat multiple sclerosis (MS) and other autoimmune diseases, the scientists said. The study, “microRNA-142–mediated repression of phosphodiesterase 3B […]

INSYS Therapeutics Inc. (NASDAQ:INSY) and Alder BioPharmaceuticals Inc. (NASDAQ:ALDR), both competing one another are Biotechnology companies. We will compare their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Earnings Valuation In table 1 we can see INSYS Therapeutics Inc. and Alder BioPharmaceuticals Inc.’s gross revenue, earnings per share and valuation. Profitability Table 2 […]

Sio Capital Management Llc decreased its stake in Gw Pharmaceuticals Plc (GWPH) by 26.13% based on its latest 2019Q1 regulatory filing with the SEC. Sio Capital Management Llc sold 22,000 shares as the company’s stock rose 19.15% with the market. The institutional investor held 62,186 shares of the major pharmaceuticals company at the end of […]

GW Pharmaceuticals’ cannabis-based epilepsy treatment, Epidiolex, scored a favorable review from FDA staff Tuesday, ahead of an advisory committee meeting scheduled later this week. The company provided “substantial evidence” of the drug’s effectiveness in treating two rare forms of epilepsy. “Although the review is still ongoing, the risk-benefit profile established by the data in the application […]

(This is an abridged version of a story that appears in the July issue of Marijuana Business Magazine.) So, you’re starting a marijuana business or thinking about changing the name of your established cannabis company. It’s not as simple as making a pun playing off marijuana or incorporating words such as “420,” “canna” or “green” into a […]

A manufacturing facility that Novartis discarded because of declining generics sales is getting a new life. The plant near Boulder, Colorado, will be converted to produce CBD products from hemp by a company riding that wave. Mile High Labs says it closed the deal last week, paying Novartis $18.75 million for the 400,000-square-foot Sandoz production […]

Transdermal is a route of administration where active ingredients are delivered across the skin for systematic distribution. Transdermal gel is a medication that is applied and absorbed directly through the skin which can provide both local and systemic effects. Different pathways by which drugs can cross the skins and reach systematic circulations are- transcellular pathway, […]

If that many Wisconsinites believe adults should use marijuana for fun, we need to look at the unintended consequences. Especially for the youth who will inevitably tap into adult supplies. Research shows that: • Marijuana and certain cannabinoid compounds can be temporarily effective for pain control and relief from some disease symptoms and chemotherapy side […]

The cannabidiol marketplace is likely to witness significant RD investment in the pharmaceutical industry as a broad-spectrum pharmaceutical therapeutics. Multiple scientific studies have shown promising results of cannabidiol for its potential in the treatment of a number of diseases. Following which the cannabidiol market is marked by a considerable cannabidiol therapeutics getting FDA approval or […]

Intec Pharma Ltd. (NASDAQ:NTEC) and Avadel Pharmaceuticals plc (NASDAQ:AVDL) are two firms in the Biotechnology that compete against each other. Below is a comparison of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Valuation and Earnings In table 1 we can see Intec Pharma Ltd. and Avadel Pharmaceuticals plc’s top-line revenue, earnings […]

Zynerba Pharmaceuticals (NASDAQ:ZYNE) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report released on Thursday, July 11th, BidAskClub reports. Several other research analysts have also recently commented on the stock. HC Wainwright restated a “buy” rating on shares of Zynerba Pharmaceuticals in a report on Monday, […]

Dog owners are all-too-familiar with the stress of seeing their pups in pain — and not knowing how to fix it. From arthritis to general aches and pains, there are many conditions that are difficult to treat. And when none of the traditional treatment options work, owners are starting to look for new, innovative ways […]